Shopping Cart
- Remove All
Your shopping cart is currently empty
SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $176 | In Stock | |
| 2 mg | $259 | In Stock | |
| 5 mg | $433 | In Stock | |
| 10 mg | $592 | In Stock | |
| 25 mg | $912 | In Stock |
| Description | SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer. |
| Synonyms | SDZ62434, SDZ 62 434 |
| Molecular Weight | 416.39 |
| Formula | C23H27Cl2N3 |
| Cas No. | 115621-95-9 |
| Smiles | C12=NCCN1C(C3=CC=C(CN4CCCCC4)C=C3)=CC5=C2C=CC=C5.Cl.Cl |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.